Cargando…
High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population – first results from a cohort study in Southern Sweden
BACKGROUND: Vaccine effectiveness against COVID-19 needs to be assessed in diverse real-world population settings. METHODS: A cohort study of 805,741 residents in Skåne county, Southern Sweden, aged 18–64 years, of whom 26,587 received at least one dose of the BNT162b2 vaccine. Incidence rates of CO...
Autores principales: | Björk, Jonas, Inghammar, Malin, Moghaddassi, Mahnaz, Rasmussen, Magnus, Malmqvist, Ulf, Kahn, Fredrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500302/ https://www.ncbi.nlm.nih.gov/pubmed/34586934 http://dx.doi.org/10.1080/23744235.2021.1982144 |
Ejemplares similares
-
Surveillance of COVID-19 vaccine effectiveness: a real-time case–control study in southern Sweden
por: Björk, Jonas, et al.
Publicado: (2022) -
Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities – surveillance results from southern Sweden, July 2021 to January 2022
por: Kahn, Fredrik, et al.
Publicado: (2022) -
COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants – surveillance results from southern Sweden, December 2021 to March 2022
por: Björk, Jonas, et al.
Publicado: (2022) -
A regression discontinuity analysis of the social distancing recommendations for older adults in Sweden during COVID-19
por: Bonander, Carl, et al.
Publicado: (2022) -
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)